LY96 and early-onset autosomal dominant Alzheimer disease: Additionally, DHM targets myeloid differentiation protein 2 (MD2) to inhibit the activation of TLR4 signaling, thereby suppressing neuroinflammation and enhancing cognition in mice with Alzheimer’s disease (Pei et al., 2023).